Clifford Chance advised healthcare group Fresenius and its Spanish subsidiary QuironSalud on the deal.Fresenius sells its 70% stake in IDCQ CRP, a co-holding entity of the…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Marco Zingaro
…
This content is for Standard 1 Year members only. LoginJoin Now